Medicap Healthcare IPO vs Supreet Chemicals IPO

Comparison between Medicap Healthcare IPO and Supreet Chemicals IPO.

IPO Details

Medicap Healthcare IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Supreet Chemicals IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Medicap Healthcare IPO is up to ₹240.00 Cr whereas the issue size of the Supreet Chemicals IPO is up to ₹499.00 Cr. The final issue price of Medicap Healthcare IPO is and of Supreet Chemicals IPO is .

 Medicap Healthcare IPOSupreet Chemicals IPO
Face Value₹10 per share₹2 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final)
Discount (Retail)
Discount (Employee)
Market Lot Size
Fresh Issue Size0 shares0 shares
Fresh Issue Size (Amount)up to ₹240.00 Crup to ₹499.00 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total0 shares0 shares
Issue Size Total (Amount)up to ₹240.00 Crup to ₹499.00 Cr

IPO Timetable

Medicap Healthcare IPO opens on , while Supreet Chemicals IPO opens on . The closing date of Medicap Healthcare IPO and Supreet Chemicals IPO is , and , respectively.

Financials & KPIs

Medicap Healthcare IPO P/E ratio is , as compared to Supreet Chemicals IPO P/E ratio of .

 Medicap Healthcare IPOSupreet Chemicals IPO
Financials

Company Financials (Restated Consolidated)

Medicap Healthcare Ltd.'s revenue increased by 7% and profit after tax (PAT) rose by 11% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 202431 Mar 2023
Assets216.29105.8998.35
Total Income109.91103.0572.60
Profit After Tax26.6223.9014.79
EBITDA37.1635.6822.67
NET Worth110.8484.2160.32
Total Borrowing88.096.9826.77
Amount in ₹ Crore

Company Financials (Restated)

Supreet Chemicals Ltd.'s revenue increased by 52% and profit after tax (PAT) rose by 103% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 202431 Mar 2023
Assets519.15338.76226.09
Total Income369.15243.27314.73
Profit After Tax51.9225.5956.34
EBITDA78.4240.3396.25
NET Worth237.21186.48162.16
Reserves and Surplus224.51173.78149.46
Total Borrowing200.7080.894.66
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)9881.26
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap
ROE27.30%24.51%
ROCE17.67%19.61%
Debt/Equity0.670.85
EPS
RoNW24.02%24.51%

Shares Offered

In the Medicap Healthcare IPO Retail Individual Investors (RII) are offered 0 shares while in Supreet Chemicals IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Medicap Healthcare IPO and 0 shares in Supreet Chemicals IPO.

 Medicap Healthcare IPOSupreet Chemicals IPO
Anchor Investor Reservation0 shares0 shares
Market Maker Reservation0 shares0 shares
QIB0 shares0 shares
NII0 shares0 shares
RII0 shares0 shares
Employee0 shares0 shares
Others
Total0 shares0 shares

Bids Received (Subscription)

Medicap Healthcare IPO subscribed in total, whereas Supreet Chemicals IPO subscribed .

Compare with others

Compare:

Medicap Healthcare IPO Vs Supreet Chemicals IPO